APN
APN
ASPEN PHARMACARE HOLDINGS LIMITED - TRADING STATEMENT
Aspen Pharmacare Holdings Limited ("Aspen")
(Incorporated in the Republic of South Africa)
(Registration Number 1985/022935/06)
Share Code: APN ISIN: ZAE000066692
TRADING STATEMENT
Shareholders are advised that Aspen anticipates that headline earnings per share
and earnings per share for the six months ended 31 December 2005 (accounted for
in terms of International Financial Reporting Standards ("IFRS")) will exceed
those of the restated previous interim period ended 31 December 2004 by between
40% and 45%. Headline earnings per share and earnings per share for the
comparative period have been restated to comply with IFRS.
Had Aspen continued to account for its results in terms of South African GAAP,
headline earnings per share and earnings per share would have shown increases of
a similar range on the reported results for the six months ended 31 December
2004.
The conversion to IFRS has resulted in a reduction in headline earnings per
share and earnings per share of between 6% and 8% for both the six month periods
ended 31 December 2005 and 31 December 2004. Material items contributing to
these reductions are: share-based payment expenses and amortisation on
reinstatement of intangible assets previously written off.
The financial results on which this trading statement has been based have not
been reviewed or reported on by Aspen"s external auditors. Aspen"s interim
results are expected to be published on SENS on 27 February 2006.
Sandton
9 February 2006
Sponsor: Investec Bank Limited
Date: 09/02/2006 04:51:24 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
